Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (161-170 of 396) with videos related to

Pageof 40
Sort By:
Bulletin Du Cancer|August 6, 2009
[A difficult end of life]Julie Traclet, Dominique Arpin, Laurence Gérinière, et al.
Cancer Treatment Reviews|January 26, 2024
Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicityRayan Bensenane, Sylvie Helfre, Kim Cao, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastasesNicolas Girard, Vincent Cottin, François Tronc, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2019
Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018Jordi Remon, Myung-Ju Ahn, Nicolas Girard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Promising Candidate Prognostic Biomarkers in [<sup>18</sup>F]FDG PET Images: Evaluation in Independent Cohorts of Non-Small Cell Lung Cancer PatientsNarinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Captier, et al.
Oncology and Therapy|September 14, 2025
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST StudyBenoît Godbert, Elisa Gobbini, Chantal Decroisette, et al.
Bulletin Du Cancer|December 9, 2022
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]David Malka, Nicolas Girard, David M Smadja, et al.
The Oncologist|May 8, 2025
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101Nicolas Girard, Qingqing Xu, D Ross Camidge, et al.
Bulletin Du Cancer|July 14, 2009
[A difficult diagnosis]Véronique Porot, Laurence Gérinière, Pierre-Jean Souquet, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Pageof 40

Showing results (161-170 of 396) with videos related to

Sort By:
Pageof 40
Bulletin Du Cancer|August 6, 2009
[A difficult end of life]Julie Traclet, Dominique Arpin, Laurence Gérinière, et al.
Cancer Treatment Reviews|January 26, 2024
Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicityRayan Bensenane, Sylvie Helfre, Kim Cao, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastasesNicolas Girard, Vincent Cottin, François Tronc, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2019
Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018Jordi Remon, Myung-Ju Ahn, Nicolas Girard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Promising Candidate Prognostic Biomarkers in [<sup>18</sup>F]FDG PET Images: Evaluation in Independent Cohorts of Non-Small Cell Lung Cancer PatientsNarinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Captier, et al.
Oncology and Therapy|September 14, 2025
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST StudyBenoît Godbert, Elisa Gobbini, Chantal Decroisette, et al.
Bulletin Du Cancer|December 9, 2022
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]David Malka, Nicolas Girard, David M Smadja, et al.
The Oncologist|May 8, 2025
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101Nicolas Girard, Qingqing Xu, D Ross Camidge, et al.
Bulletin Du Cancer|July 14, 2009
[A difficult diagnosis]Véronique Porot, Laurence Gérinière, Pierre-Jean Souquet, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Pageof 40